Saw palmetto
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Saw palmetto
- DrugBank Accession Number
- DB14360
- Background
Saw palmetto is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Approved, Experimental, Investigational
- Synonyms
- Abal Fructus
- Brahea Serrulata Fruit
- Chamaerops Serrulata Fruit
- Corypha Obliqua Fruit
- Corypha Repens Fruit
- Diglossophyllum Serrulatum Fruit
- Sabal Palm Fruit
- Sabal Serrulata
- Sabal Serrulata Fruit
- Sabalis Serrulatae Fructus (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols))
- Saw Palmetto Berry
- Saw Palmetto Extract
- Saw Palmetto Fruit
- Saw Palmetto Fruit (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols))
- Saw Palmetto Fruit Extract
- Serenoa
- Serenoa Preparation
- Serenoa Repens Fruit
- Serenoa Repens Fruit Dry Extract
- Serenoa Repens Fruit Ethanol Extract
- Serenoa Serrulata Fruit
- Serenoa Serrulata Fruit Extract
- Serenoa Serrulata Fruit Powder
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat B vitamin deficiency Combination Product in combination with: Zinc (DB01593), Selenium (DB11135), Pyridoxine (DB00165), Tocopherol (DB11251), Cyanocobalamin (DB00115), Folic acid (DB00158), Lycopene (DB11231), Vitamin E (DB00163) •••••••••••• •••••••• •••••• Treatment of Discomfort with urination ••• ••• ••••• ••••••• Used in combination for symptomatic treatment of Urination impaired Combination Product in combination with: Urtica dioica pollen (DB10763) •••••••••••• ••••• ••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Ethical Herbals Urinary Flow Capsule 160 mg / cap Oral Ashbury Research Corporation Not applicable Not applicable Canada SAMETTO Capsule 320 mg Oral บริษัท เมก้า ไลฟ์ไซแอ็นซ์ จำกัด (มหาชน) 2008-03-31 Not applicable Thailand Saw Palmetto Berries 500mg Capsule 500 mg Oral General Nutrition Canada Inc. 1999-12-17 2007-08-01 Canada Saw Palmetto Tincture - Liq 0.25 Gm/ml Liquid 250 mg / mL Oral Holista Health (Canada) Inc. 1996-12-31 2001-08-01 Canada แบลคมอร์ส โปรเซอเรน Capsule 160 mg Oral บริษัท แบลคมอร์ส จำกัด 2009-06-11 Not applicable Thailand - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Cream Saw palmetto (6.3 g/30g) + Glycerin (4.5 g/30g) Cream Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US Medi Megaton 2080 Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g) Powder Topical Mbg Inc (Korea Institute of Science Development) 2016-10-15 2017-10-15 US Medi Megaton 2080 Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g) Powder Topical Mbg Inc (Korea Institute of Science Development) 2016-10-16 2017-10-16 US PROSTAGOOD PLUS KAPSÜL, 120 ADET Saw palmetto (160 mg) + Urtica dioica pollen (120 mg) Capsule Oral ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 2006-03-22 Not applicable Turkey PROSTAGOOD PLUS KAPSÜL, 60 ADET Saw palmetto (160 mg) + Urtica dioica pollen (120 mg) Capsule Oral ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 2006-03-22 Not applicable Turkey - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Medi Megaton 2080 Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g) Powder Topical Mbg Inc (Korea Institute of Science Development) 2016-10-15 2017-10-15 US Medi Megaton 2080 Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g) Powder Topical Mbg Inc (Korea Institute of Science Development) 2016-10-16 2017-10-16 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- J7WWH9M8QS
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Basic Science Benign Prostatic Hyperplasia (BPH) 1 4 Completed Treatment Benign Prostatic Hyperplasia (BPH) 1 4 Recruiting Treatment Benign Prostatic Hyperplasia (BPH) 1 4 Unknown Status Treatment Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia 1 3 Completed Treatment Benign Prostatic Hyperplasia (BPH) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Cutaneous Capsule Oral 800 mg / cap Capsule Oral 160 mg / cap Powder Topical Capsule Oral Capsule Oral Capsule Oral 320 mg Capsule Oral 500 mg Liquid Not applicable 1 kg/1kg Liquid Oral 250 mg / mL Capsule, coated Oral Capsule Oral 160 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at May 19, 2024 10:11